Package 61703-349-36

{"route": ["INTRAVENOUS"], "spl_id": "9c52ca8e-58dd-4117-a5bc-f277e79abb19", "openfda": {"unii": ["042LAQ1IIS"], "rxcui": ["1726319", "1726324", "1726492"], "spl_set_id": ["5c527c2e-9062-4afe-dbbb-f650db3a340f"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-09)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "61703-349-09", "marketing_start_date": "20080227"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-16)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "61703-349-16", "marketing_start_date": "20080227"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349-36)  / 25 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "61703-349-36", "marketing_start_date": "20080227"}], "brand_name": "Irinotecan Hydrochloride", "product_id": "61703-349_9c52ca8e-58dd-4117-a5bc-f277e79abb19", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "61703-349", "generic_name": "Irinotecan Hydrochloride", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan Hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA077915", "marketing_category": "ANDA", "marketing_start_date": "20080227", "listing_expiration_date": "20261231"}